Fundraising FoxDiamond Edge Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesO2h VenturesParkwalk AdvisorsWren Capital
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)inJoshua Nixon(Founder)
Co-investorsAlumni VenturesCollaborative FundDnx VenturesGaingelsPangaea Ventures Us Inc.Portfolia+9 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.